Welcome to our dedicated page for RACWI US ETF news (Ticker: RAUS), a resource for investors and traders seeking the latest updates and insights on RACWI US ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RACWI US ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RACWI US ETF's position in the market.
RAFI Indices has launched the Research Affiliates Cap-Weighted US ETF (RAUS) on NASDAQ, designed to track the Research Affiliates Cap-Weighted Index (RACWI). The ETF introduces a novel approach to index construction by selecting companies based on fundamental measures before applying market cap weighting.
The RACWI methodology uses four equally weighted fundamental metrics: adjusted sales, adjusted cash flow, dividends plus buybacks, and book value plus intangibles. Since its 2021 launch, the index has outperformed the S&P 500 by 81 basis points annually with a tracking error under 60 basis points, maintaining over 95% overlap with S&P 500 holdings.
The ETF aims to address inefficiencies in traditional cap-weighted indices while maintaining their benefits of scalability, low cost, and low turnover.
FAQ
What is the current stock price of RACWI US ETF (RAUS)?
